US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

205.96

-4.5700-2.17%

Post-market: 205.960.00000.00%19:30 EDT

Volume:1.55M

Turnover:321.61M

Market Cap:10.45B

PE:32.63

High:211.73

Open:210.09

Low:205.84

Close:210.53

52wk High:217.12

52wk Low:144.65

Shares:50.75M

Float Shares:50.75M

Volume Ratio:1.07

T/O Rate:3.05%

Dividend:0.34

Dividend Rate:0.16%

EPS(TTM):6.31

EPS(LYR):35.34

ROE:24.54%

ROA:0.10%

PB:1.28

PE(LYR):5.83

Loading ...

Overview Company News Filings

Regeneron Says Phase 2 Courage Trial Shows Trevogrumab Preserves Lean Mass During Semaglutide Weight Loss

Regeneron Pharmaceuticals, - Lower Doses of Trevogrumab Well Tolerated with 77% Experiencing at Least One Adverse Event

THOMSON REUTERS

Regeneron Pharmaceuticals, - Plans Phase 2 Trial of Trevogrumab with Glp-1 Therapies in Older Adults

THOMSON REUTERS

Phase 2 Courage Trial Confirms Trevogrumab Prevents Lean Mass and Muscle Loss During Glp-1 Receptor Agonist-Induced Weight Loss

THOMSON REUTERS

Regeneron Pharmaceuticals, - Trevogrumab Prevents 70% of Muscle Loss Associated with Semaglutide Treatment

THOMSON REUTERS

Oxford BioDynamics Extends Vulpes Payment Deadline in £9.15m Placing

Gilead Sciences Announces Dividend of R$ 0.2394442440 Per Unit for Brgildbdr 000

Regeneron Exec Says Co Eligible to Receive $1 Bln in Potential Milestone Payment with the Start of the First Late-Stage Trial as Part of the Deal -Conf Call

THOMSON REUTERS

Regeneron Exec Says Co Expects to Start Pivotal Study for Regn20423 Either in Late 2027 or Early 2028

THOMSON REUTERS

Regeneron Pharma Price Target Announced at $850.00/Share by Argus Research

Vir Biotechnology Names Aziz Sawaf as CFO Effective Oct. 5, 2026

Sanofi Exec Says "There is no Certainty at This Point in Time, but We are Actively Working in Order to Extend the Loss of Exclusivity of Dupixent"

THOMSON REUTERS

Sanofi CEO Says Expects the Market for Atopic Dermatitis Treatments to Nearly Double over the Next Five Years -Conf Call

THOMSON REUTERS

Vertex appoints Saha to Board of Directors

Press Release: Vertex Appoints DataRobot CEO Debanjan Saha to Board of Directors

Regeneron Pharmaceuticals, Inc. : Argus Research Raises to Buy from Hold

THOMSON REUTERS

Stocks to Watch: Micron, Alphabet, Sanofi, Nu Holdings

Sanofi’s Regeneron Fix Requires Extra Shot of M&A

Sanofi CEO Takes First Step Toward Addressing Long-Term Outlook

Sanofi to Get Pipeline Boost from Expanded Regeneron Alliance

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/IBB/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"iShares Biotechnology ETF","latestPrice":205.96,"timestamp":1790884800000,"preClose":210.53,"halted":0,"volume":1546879,"hourTrading":{"tag":"盘后","latestPrice":205.96,"preClose":205.96,"latestTime":"19:30 EDT","volume":7162,"amount":1475288.405,"timestamp":1790897406045,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.021707120125397772,"floatShares":50750000,"shares":50750000,"eps":6.311863,"marketStatus":"Closed","change":-4.57,"latestTime":"10-01 16:00:00 EDT","open":210.085,"high":211.73,"low":205.84,"amount":321610885.85687,"amplitude":0.027977,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790928000000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":210.53,"sharesOutstanding":49450000,"nav":210.463323,"aum":11112463454.4,"dividendRate":0.001637,"bidAskSpread":0.00039,"preHourTrading":{"tag":"盘前","latestPrice":210,"preClose":210.53,"latestTime":"09:27 EDT","volume":198,"amount":41672.93328,"timestamp":1790861278000,"change":-0.53,"changeRate":-0.002517,"amplitude":0.010126},"postHourTrading":{"tag":"盘后","latestPrice":205.96,"preClose":205.96,"latestTime":"19:30 EDT","volume":7162,"amount":1475288.405,"timestamp":1790897406045,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.06677,"impliedVol":0.2407,"impliedVolPercentile":0.5976},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50750000,"roa":"0.10%","roe":"24.54%","lyrEps":35.344796,"volumeRatio":1.06677,"shares":50750000,"dividePrice":0.3371,"high":211.73,"amplitude":0.027977,"preClose":210.53,"low":205.84,"week52Low":144.65,"pbRate":"1.28","psRate":"251.48","week52High":217.12,"institutionHeld":0,"latestPrice":205.96,"eps":6.311863,"divideRate":0.001637,"volume":1546879,"delay":0,"ttmEps":6.311863,"open":210.085,"prevYearClose":168.77,"prevWeekClose":209.77,"prevMonthClose":210.53,"prevQuarterClose":210.53,"fiveDayClose":209.25,"twentyDayClose":213.8,"sixtyDayClose":196.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"IBB","amount":0.011194,"announcedDate":"2026-09-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-09-18"},{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"},{"executeDate":"2018-06-26","recordDate":"2018-06-27","paymentDate":"2018-07-02","value":0.15606,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672813765","title":"Regeneron Says Phase 2 Courage Trial Shows Trevogrumab Preserves Lean Mass During Semaglutide Weight Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2672813765","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672813765?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:31","pubTimestamp":1790868665,"startTime":"0","endTime":"0","summary":"Regeneron says Phase 2 COURAGE trial shows trevogrumab preserves lean mass during semaglutide weight lossRegeneron reported new Phase 2 COURAGE results showing trevogrumab helped preserve muscle durin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL2GbBGj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","BK4585","IBBQ","LU1917777945.USD","LU0320765992.SGD","NDAQ","TBXU","SG9999014021.USD","LU2362540622.SGD","LU0823434740.USD","LU2023250504.SGD","IE00BQXX3F31.USD","IE00B3QW5Z07.USD","LU2237438978.USD","IE00BN0W2T93.GBP","LU0053666078.USD","LU0109394709.USD","IE00B64PRP62.GBP","IE00BQXX3C00.GBP","BK4112","IE00BGHQF748.EUR","IE00BQXX3D17.EUR","BCDF","IBB","LU0058720904.USD","LU0823416689.USD","LU0314104364.USD","LU2106854487.HKD","BK4139","LU2089984988.USD","SG9999014039.USD","LU0889565916.HKD","LU0882574055.USD","LU2324357040.USD","SG9999014013.SGD","LU2095319765.USD","BK4588","IE00BN0W2V16.EUR","SG9999014005.SGD","LU0114720955.EUR","LU2362541273.HKD","IE00BN0W2W23.USD","LU0823434583.USD","LU2362541513.USD","LU2468319806.SGD","LU2210150020.SGD","LU0289739699.SGD","LU1974910355.USD","LU2210149790.SGD","REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672888765","title":"Regeneron Pharmaceuticals, - Lower Doses of Trevogrumab Well Tolerated with 77% Experiencing at Least One Adverse Event","url":"https://stock-news.laohu8.com/highlight/detail?id=2672888765","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672888765?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:30","pubTimestamp":1790868600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA5R1YTR:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","IBB","LU0289739699.SGD","LU2106854487.HKD","LU2089984988.USD","LU0058720904.USD","IBBQ","LU0823434740.USD","LU2362541273.HKD","TBXU","LU2237438978.USD","LU2324357040.USD","BK4585","LU0320765992.SGD","REGN","LU0823434583.USD","LU0114720955.EUR","LU0053666078.USD","LU0882574055.USD","LU1974910355.USD","BK4139","LU2468319806.SGD","LU0823416689.USD","LU0889565916.HKD","BBH","LU2023250504.SGD","LU2362541513.USD","LU1917777945.USD","LU2362540622.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672884765","title":"Regeneron Pharmaceuticals, - Plans Phase 2 Trial of Trevogrumab with Glp-1 Therapies in Older Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2672884765","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672884765?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:30","pubTimestamp":1790868600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA5R1YTR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","IBB","LU0289739699.SGD","LU2106854487.HKD","LU2089984988.USD","LU0058720904.USD","IBBQ","LU0823434740.USD","LU2362541273.HKD","TBXU","LU2237438978.USD","LU2324357040.USD","BK4585","LU0320765992.SGD","REGN","LU0823434583.USD","LU0114720955.EUR","LU0053666078.USD","LU0882574055.USD","LU1974910355.USD","BK4139","LU2468319806.SGD","LU0823416689.USD","LU0889565916.HKD","BBH","LU2023250504.SGD","LU2362541513.USD","LU1917777945.USD","LU2362540622.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672765886","title":"Phase 2 Courage Trial Confirms Trevogrumab Prevents Lean Mass and Muscle Loss During Glp-1 Receptor Agonist-Induced Weight Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2672765886","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672765886?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:30","pubTimestamp":1790868600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA5R1YTR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2089984988.USD","BK4139","IBBQ","IBB","LU1917777945.USD","LU2362541273.HKD","BBH","LU0889565916.HKD","LU0320765992.SGD","LU2106854487.HKD","LU2468319806.SGD","LU0289739699.SGD","LU2362540622.SGD","LU0058720904.USD","BK4585","LU2324357040.USD","LU0114720955.EUR","LU2362541513.USD","LU2023250504.SGD","REGN","LU0823434740.USD","LU0823434583.USD","LU1974910355.USD","LU2237438978.USD","TBXU","BK4588","LU0882574055.USD","LU0823416689.USD","LU0109394709.USD","LU0053666078.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672763000","title":"Regeneron Pharmaceuticals, - Trevogrumab Prevents 70% of Muscle Loss Associated with Semaglutide Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2672763000","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672763000?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:30","pubTimestamp":1790868600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA5R1YTR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1917777945.USD","LU2089984988.USD","LU0114720955.EUR","LU0882574055.USD","BK4139","LU1974910355.USD","LU0320765992.SGD","LU2468319806.SGD","LU0053666078.USD","LU0823434740.USD","IBB","LU2106854487.HKD","LU0823434583.USD","BK4588","LU2237438978.USD","LU0058720904.USD","LU2324357040.USD","LU0289739699.SGD","LU2362540622.SGD","LU2023250504.SGD","REGN","BBH","LU0823416689.USD","BK4585","LU2362541273.HKD","LU2362541513.USD","LU0109394709.USD","LU0889565916.HKD","TBXU","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672632267","title":"Oxford BioDynamics Extends Vulpes Payment Deadline in £9.15m Placing","url":"https://stock-news.laohu8.com/highlight/detail?id=2672632267","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672632267?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:12","pubTimestamp":1790867579,"startTime":"0","endTime":"0","summary":"Oxford BioDynamics ( ($GB:OBD) ) has provided an announcement. Oxford BioDynamics Plc, a 3D genomics-focused biotechnology company listed on AIM, p...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oxford-biodynamics-extends-vulpes-payment-deadline-in-9-15m-placing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oxford-biodynamics-extends-vulpes-payment-deadline-in-9-15m-placing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IEIH","SYNB","BK4588","TARK","BMED","OXM","BK4202","DARP","PBE","BBP","IDNA","FHLC","JDOC","LNGR","FWD","RSPH","BK4585","AGNG","GNMX","GNOM","XT","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672500697","title":"Gilead Sciences Announces Dividend of R$ 0.2394442440 Per Unit for Brgildbdr 000","url":"https://stock-news.laohu8.com/highlight/detail?id=2672500697","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672500697?lang=en_us&edition=fundamental","pubTime":"2026-10-01 21:56","pubTimestamp":1790863001,"startTime":"0","endTime":"0","summary":"Gilead Sciences announces dividend of R$ 0.2394442440 per unit for BRGILDBDR 000Gilead declared a 3Q 2026 dividend of R$ 0.2394 per unit for ISIN BRGILDBDR000.Shares trade ex-rights from Sept. 11, 202","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL7w2sZC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","LU0058720904.USD","LU1430594728.SGD","LU1571399168.USD","SG9999015986.USD","IBB","SG9999015945.SGD","MEDI","IBBQ","TMED","IE00B3T34201.USD","LU0965509101.SGD","LU1057294990.SGD","IE00B19Z3B42.SGD","BMED","LU1037948897.HKD","LU0122379950.USD","LU0114720955.EUR","LU1066051498.USD","LU1778281490.HKD","LU2089984988.USD","BK4588","IE00B19Z3581.USD","BIB","LU2357627491.SGD","SG9999015978.USD","LU1066053197.SGD","LU0861579265.USD","LU1061106388.HKD","LU0320765992.SGD","LU1934455863.HKD","LU0823416689.USD","LU1934455277.USD","LU0965509010.AUD","LU0859254822.USD","LU0889565916.HKD","BK4568","LU0965508806.USD","IE0002270589.USD","LU0965509283.SGD","LU0109394709.USD","BK4585","IE00BZ1G4Q59.USD","LU1037948541.HKD","TBXU","BK4550","IE00B7SZLL34.SGD","GILD","LU1023059063.AUD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672757352","title":"Regeneron Exec Says Co Eligible to Receive $1 Bln in Potential Milestone Payment with the Start of the First Late-Stage Trial as Part of the Deal -Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2672757352","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672757352?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:47","pubTimestamp":1790858840,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N1JO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","LU0109394709.USD","LU0889565916.HKD","LU2362540622.SGD","LU2023250504.SGD","LU2468319806.SGD","LU2089984988.USD","LU0058720904.USD","LU2106854487.HKD","LU1974910355.USD","BK4139","BK4588","BBH","LU0053666078.USD","IBB","LU0823434583.USD","IBBQ","LU0823434740.USD","LU0289739699.SGD","LU1917777945.USD","LU2362541513.USD","LU0823416689.USD","TBXU","LU0882574055.USD","LU2324357040.USD","REGN","BK4585","LU2362541273.HKD","LU0114720955.EUR","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672514757","title":"Regeneron Exec Says Co Expects to Start Pivotal Study for Regn20423 Either in Late 2027 or Early 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2672514757","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672514757?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:47","pubTimestamp":1790858840,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N1JO:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBB","LU2023250504.SGD","LU0889565916.HKD","LU2468319806.SGD","BK4139","LU0058720904.USD","LU0823434583.USD","REGN","LU0882574055.USD","BBH","LU0289739699.SGD","LU1917777945.USD","LU0823434740.USD","LU2324357040.USD","LU2237438978.USD","TBXU","LU2362540622.SGD","LU0823416689.USD","BK4588","LU0053666078.USD","LU0109394709.USD","BK4585","LU2106854487.HKD","LU0114720955.EUR","LU2362541513.USD","LU2089984988.USD","LU2362541273.HKD","LU0320765992.SGD","LU1974910355.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672573987","title":"Regeneron Pharma Price Target Announced at $850.00/Share by Argus Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2672573987","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672573987?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:46","pubTimestamp":1790858760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/REGN/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Regeneron Pharma Price Target Announced at $850.00/Share by Argus Research","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1917777945.USD","LU1974910355.USD","LU2468319806.SGD","IBB","LU0109394709.USD","LU0882574055.USD","LU2106854487.HKD","LU0889565916.HKD","LU0320765992.SGD","LU2089984988.USD","TBXU","BK4585","IBBQ","LU0114720955.EUR","REGN","LU0823434740.USD","LU2324357040.USD","LU2362540622.SGD","LU0053666078.USD","LU0823416689.USD","LU2023250504.SGD","LU0289739699.SGD","BBH","LU2362541513.USD","LU0823434583.USD","BK4139","LU0058720904.USD","LU2237438978.USD","LU2362541273.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672752471","title":"Vir Biotechnology Names Aziz Sawaf as CFO Effective Oct. 5, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672752471","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672752471?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:31","pubTimestamp":1790857866,"startTime":"0","endTime":"0","summary":"Vir Biotechnology names Aziz Sawaf as CFO effective Oct. 5, 2026Vir Biotechnology appointed Aziz Sawaf as executive vice president and chief financial officer, effective Oct. 5, 2026.Sawaf will overse","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL7MZVyh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","LU1066053197.SGD","LU0234570918.USD","LU1674673428.USD","BMED","GILD","SG9999015945.SGD","SG9999015952.SGD","BK4585","IE00BZ1G4Q59.USD","LU1061106388.HKD","BK4532","LU2089984988.USD","IE00B7SZLL34.SGD","LU0861579265.USD","LU2324357040.USD","IBB","VIR","LU0889565916.HKD","LU1037948541.HKD","LU0320765992.SGD","BK4588","BK4583","TBXU","LU0058720904.USD","LU0965508806.USD","BIB","LU0965509101.SGD","IE00B3T34201.USD","ZYME","LU2087621335.USD","TMED","BK4578","LU2357627491.SGD","IE0002270589.USD","LU2468319806.SGD","LU0965509283.SGD","LU1778281490.HKD","LU0859254822.USD","LU0965509010.AUD","BK4139","LU1037948897.HKD","MEDI","IBBQ","BK4566","LU1430594728.SGD","LU1066051498.USD","LU1571399168.USD","IE00B19Z3B42.SGD","LU1674673691.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672875732","title":"Sanofi Exec Says \"There is no Certainty at This Point in Time, but We are Actively Working in Order to Extend the Loss of Exclusivity of Dupixent\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2672875732","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672875732?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:24","pubTimestamp":1790857444,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N0R2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0114720955.EUR","LU0058720904.USD","LU0823434583.USD","BBH","LU0109394709.USD","REGN","LU2362540622.SGD","LU2023250504.SGD","LU1974910355.USD","LU0823434740.USD","LU0823416689.USD","LU0889565916.HKD","LU2237438978.USD","LU2324357040.USD","LU2362541513.USD","LU2362541273.HKD","BK4588","IBB","BK4585","LU2106854487.HKD","BK4139","TBXU","IBBQ","LU0289739699.SGD","LU1917777945.USD","LU0053666078.USD","LU2468319806.SGD","LU0882574055.USD","LU0320765992.SGD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672752928","title":"Sanofi CEO Says Expects the Market for Atopic Dermatitis Treatments to Nearly Double over the Next Five Years -Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2672752928","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672752928?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:24","pubTimestamp":1790857444,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N0R2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LU0114720955.EUR","LU2468319806.SGD","REGN","LU2089984988.USD","LU2362540622.SGD","BK4585","LU0882574055.USD","IBBQ","LU1917777945.USD","LU2106854487.HKD","LU0289739699.SGD","LU0058720904.USD","LU0053666078.USD","LU0889565916.HKD","BK4588","LU0320765992.SGD","LU2023250504.SGD","IBB","LU0823416689.USD","LU2362541513.USD","LU2324357040.USD","LU0823434583.USD","LU0109394709.USD","LU1974910355.USD","LU2237438978.USD","LU2362541273.HKD","TBXU","BBH","LU0823434740.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672752609","title":"Vertex appoints Saha to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672752609","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672752609?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:11","pubTimestamp":1790856687,"startTime":"0","endTime":"0","summary":"Vertex (VERX) announced the appointment of Debanjan Saha to its Board of Directors, effective October 7, 2026. Published first on TheFly – the ulti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-appoints-saha-to-board-of-directors-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-appoints-saha-to-board-of-directors-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","IE00BJT1NW94.SGD","BK4533","VRTX","BK4588","IE00B19Z3B42.SGD","PBE","LU1559883803.SGD","BK4585","LU2324357040.USD","LU1778281490.HKD","IBBQ","GNMX","LU1674673691.USD","SG9999001176.SGD","LU0566484027.USD","LU0823416689.USD","LU2362541273.HKD","IE00B19Z9P08.USD","IE0002141913.USD","BBH","SG9999013999.USD","LU0889565916.HKD","IE00BZ9MQY76.HKD","LU2417539215.USD","IE00BJJMRZ35.SGD","LU2362540622.SGD","LU2456880835.USD","TBXU","BK4567","LU0289739699.SGD","IDNA","LU0256863811.USD","IE00B4R5TH58.HKD","IE0002270589.USD","VERX","LU0320765992.SGD","BIB","LU0234570918.USD","LU2089984988.USD","IE00B894F039.SGD","LU2362541513.USD","LU2236285917.USD","LU0058720904.USD","IE00B19Z3581.USD","SG9999001176.USD","LU0061475181.USD","LU0417517546.SGD","IBB","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672475411","title":"Press Release: Vertex Appoints DataRobot CEO Debanjan Saha to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672475411","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672475411?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:00","pubTimestamp":1790856000,"startTime":"0","endTime":"0","summary":"KING OF PRUSSIA, Pa., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) (\"Vertex\" or the \"Company\"), the Decision-to-Defense(TM) global indirect tax and compliance company, today announced ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNMX","LU0058720904.USD","LU2417539215.USD","LU0320765992.SGD","LU1069344957.HKD","QTOC","TM","LU0061475181.USD","03160","BK4023","VTHR","LU2362541513.USD","BIB","BK4585","LU1430594728.SGD","LU2362541273.HKD","TBXU","LU2362540622.SGD","LU2324357040.USD","BBH","IE00B19Z3581.USD","LU2462157665.USD","IBB","AGIX","LU1035775433.USD","LU1559883803.SGD","PBE","ARTY","VRTX","BK4139","AIPO","LU0234570918.USD","LU1674673428.USD","IE00B2B36J28.USD","IBBQ","IE0002141913.USD","IE00B19Z3B42.SGD","LU0079474960.USD","CHAT","BK4588","IE0002270589.USD","LU0566484027.USD","BK4567","LU2089984988.USD","LU2237438978.USD","VERX","IDNA","LU2236285917.USD","BK4533","SGXZ57979304.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672594467","title":"Regeneron Pharmaceuticals, Inc. : Argus Research Raises to Buy from Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2672594467","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672594467?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:55","pubTimestamp":1790852151,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N0YE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TBXU","LU2468319806.SGD","LU2023250504.SGD","LU2324357040.USD","REGN","LU0053666078.USD","LU0889565916.HKD","LU0114720955.EUR","LU1917777945.USD","LU1974910355.USD","BK4588","LU2362541513.USD","IBBQ","LU2237438978.USD","LU0823434583.USD","LU2362540622.SGD","LU0320765992.SGD","LU0058720904.USD","BK4139","LU2362541273.HKD","LU0109394709.USD","BBH","LU0882574055.USD","LU0823416689.USD","LU0823434740.USD","LU2106854487.HKD","LU0289739699.SGD","BK4585","IBB","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672756885","title":"Stocks to Watch: Micron, Alphabet, Sanofi, Nu Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2672756885","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672756885?lang=en_us&edition=fundamental","pubTime":"2026-10-01 17:59","pubTimestamp":1790848740,"startTime":"0","endTime":"0","summary":"Micron Technology (MU): Shares of the semiconductor company edged down premarket even though it posted a profit and revenue surge for its fiscal fourth quarter.Alphabet (GOOGL): Shares the Google pare","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2168564149.EUR","IE00B19Z8X17.USD","GOOL","LU2896262040.SGD","AIS","LU1791710582.SGD","IE00B5949003.HKD","LU2023251221.USD","LU2543165471.USD","LU0708995401.HKD","LU2098885051.SGD","LU2462591277.SGD","LU0444973449.USD","LU0466842654.USD","LU0784385170.HKD","BK4538","LU1303367103.USD","LU2125909593.SGD","LU0345774631.USD","BK4077","MUD","LU1880398471.USD","IBBQ","LU1815333072.USD","BK4598","LU0456842615.SGD","AIQ","LU2028103732.USD","SG9999000418.SGD","BK7507","SGXZ51526630.SGD","LU2048586759.USD","LU1815336760.USD","TRUC","LU0130102774.USD","IE00B19Z9505.USD","WUGI","LU0143863198.USD","IE00BFMHRM44.USD","LU1280957306.USD","IE00B7SZLL34.SGD","LU2360107671.USD","LU0094547139.USD","LU2237438978.USD","LU0124676726.USD","LU2265009873.SGD","PTF","LU0690374961.EUR","TRFK","LU0006306889.USD","LU2360107168.USD","LU1935043023.USD","LU2097829019.USD","LU0056508442.USD","LU0070217475.USD","LU0784383803.USD","LU1551013425.SGD","LU0214875030.USD","LU0130517989.USD","IE00BJTD4V19.USD","XNTK","BK4576","IE0009356076.USD","LU2286300806.USD","LU1732799900.SGD","LU0323239441.USD","IE00BD6J9T35.USD","IE00BJTD4N35.SGD","LU1917777945.USD","LU2106854487.HKD","SGXZ99366536.SGD","LU1642822529.SGD","LU0353189680.USD","IE0001KFT4U8.USD","LU1868836757.USD","GOU","SMU00main","LU0289960550.SGD","LU0097036916.USD","LU2023250504.SGD","SGXZ44715902.SGD","LU2326559502.SGD","LU0823416689.USD","LU2462157665.USD","IE00BHPRN162.USD","LU0077335932.USD","LU1989764748.USD","LU2087625088.SGD","LU2357305700.SGD","BK4581","LU0792757196.USD","LU1228905540.USD","IE00BGV7N243.SGD","LU1989764664.SGD","LU2746668461.USD","LU0052756011.USD","LU0726765562.USD","LU2023250330.USD","LU1670628061.USD","IE00B1BXHZ80.USD","LU1670756490.USD","IE00BN8TJ469.HKD","LU2596442595.SGD","LU0648001328.SGD","LU2213496289.HKD","LU0476273544.USD","LU0882574139.USD","IE00BMPRXR70.SGD","LU0985320562.USD","IE00B19Z3581.USD","LU1221951129.SGD","LU0689626769.HKD","LU0061474960.USD","LU0345769631.USD","LU2471134523.USD","EGGY","LU0130103400.USD","TTXU","LU0868494708.USD","LU0251131958.USD","LU1629891620.HKD","LU1803068979.SGD","LU0312595415.SGD","BK4574","LU0210535034.USD","SG9999001424.SGD","LU0976567544.SGD","LU1571399168.USD","LU0265550359.USD","LU1153585028.USD","IETC","BK4146","SG9999014898.SGD","LU0823046577.USD","LU0889565916.HKD","LU0472753341.HKD","LU2456880835.USD","LU2092937148.SGD","LU0251142724.SGD","LU0114720955.EUR","SG9999014542.SGD","LU0251132253.USD","LU1145028129.USD","LU1720051108.HKD","LU1066051498.USD","LU2362541513.USD","BK4575","SG9999014906.USD","LU1585245621.USD","IE00B1XK9C88.USD","VOX","SNYNF","BK4134","LU1043141123.HKD","LU0265267285.USD","LU0323591593.USD","LU0138981039.USD","DISK","LU0553294199.USD","LU2250418816.HKD","LU0157215616.USD","IE00BQXX3F31.USD","LU1496350171.SGD","SG9999015358.SGD","NU","LU2125909247.SGD","IE00BKPKM429.USD","LU0274383776.USD","LU0265550946.USD","IE00BKDWB100.SGD","LU0314104364.USD","SG9999017495.SGD","LU1435385759.SGD","LU0477156797.USD","IE000MB6IJN5.SGD","LU2404859667.USD","LU1861217088.USD","SG9999014575.USD","LU2404859741.USD","LU0949170426.SGD","LU1201861249.SGD","LU0477156953.USD","LU0310800379.SGD","LU2242650005.HKD","LU2111349929.HKD","IE00B19Z8W00.USD","BK4602","LU2491050071.SGD","LU2168564065.EUR","LU0196696453.USD","GOOY","LU0143863784.USD","LU0081259029.USD","LU1228905037.USD","LU2430703095.HKD","LU1196500208.SGD","IE000SO60NU8.SGD","LU2592432038.USD","SG9999015945.SGD","IE0004091025.USD","LU1935042488.USD","LU0070302665.USD","LU1316542783.SGD","BK4612","LU1267930573.SGD","CMAG","IE000WAW04H5.SGD","LU0048584097.USD","LU0069063385.USD","LU1923622614.USD","BK4207","BK4559","LU0787776722.HKD","LU0531971322.HKD","LU1894683348.USD","LU0395794307.EUR","IE00B7KXQ091.USD","LU0964807845.USD","LU2275660780.HKD","IE00BJJMRX11.SGD","MIC","LU2023250843.SGD","BK4561","LU1880398554.USD","BK4579","LU0820561909.HKD","LU0053666078.USD","IE000F7OJYX1.SGD","LU2087621335.USD","LU1202635105.USD","LU1674673428.USD","BK4588","LU0557290698.USD","IE00BQXX3D17.EUR","LU1003077747.HKD","LU2097344357.USD","LU1923623000.USD","IE00BDCRKT87.USD","LEGR","MUG","LU0234570918.USD","IE00BJJMRY28.SGD","WLDR","HBMX","LU0096364046.USD","LU0187121727.USD","IE00BJLML261.HKD","VGT","LU1883839398.USD","LU2089984988.USD","XLC","JGRO","LU2290526834.HKD","IE00BDRTCR15.USD","LU1084165304.USD","LU0820561818.USD","LU2362540622.SGD","NUG","IE0004445015.USD","LU1046421795.USD","LU2362541273.HKD","LU0225283273.USD","LU1116320737.USD","LU2462591350.SGD","SG9999014880.SGD","LU0170899867.USD","REGN","LU0048575426.USD","PSI","LU0511384066.AUD","LU0158827781.USD","BAI","LU0267386448.USD","IE00BQXX3C00.GBP","GB00B4QBRK32.GBP","LU0215105999.USD","HK0000304797.USD","LU1301847155.USD","LU2357627491.SGD","SG9999015341.SGD","LU0823411888.USD","LTL","LU0496365809.HKD","LU1144417596.USD","LU2999663052.SGD","IE0034235295.USD","IXN","LU1366192091.USD","LU2381873111.SGD","BK4554","LU1261432733.SGD","LU2045819591.USD","RULE","LU0210533765.USD","HK0000304805.HKD","LU0642271901.SGD","LU2491050154.USD","USXF","MUYY","LU1232071149.USD","BK4592","LU2360032135.SGD","LU2211815571.USD","LU0648000940.SGD","LU1066053197.SGD","LU2430703178.SGD","SG9999015986.USD","EMSF","LU0048573561.USD","SG9999018865.SGD","LYC.AU","LU0949170772.SGD","HK0000914686.HKD","LU2505996509.AUD","LU2750360641.GBP","LU0050427557.USD","LU0354030438.USD","IE00BKVL7J92.USD","LU1481012133.USD","LU2125910500.SGD","LU1066051811.HKD","LU1778281490.HKD","LU0174119429.USD","LU0345768740.USD","LU2471134879.HKD","LU1861220033.SGD","LU2430703251.USD","SGXZ31699556.SGD","ACN","LU0128525689.USD","LU0203345920.USD","LU0348723411.USD","LU1496350502.SGD","FCOM","LU0912757837.SGD","LU1732800096.USD","LU1043141396.HKD","LU0882574055.USD","IE0004086264.USD","GOOW","SG9999015978.USD","SOXQ","LU0082616367.USD","LU0128525929.USD","LU0823434740.USD","LU2458330243.SGD","LU0133085943.USD","SNPE","LU0320765992.SGD","LU0058720904.USD","LU1244550577.SGD","BK4558","BK4605","SGXZ80539844.SGD","FTXL","IE00B1B80R65.USD","LU2247934214.USD","LU0345769128.USD","LU1221951046.USD","FDTX","EFIV","LU0316494557.USD","LU1988902786.USD","CHPX","LU2468319806.SGD","SG9999002224.SGD","LU0640476718.USD","LU2433249047.HKD","LU0417517546.SGD","LU1674673691.USD","LU0784384876.USD","LU2168564495.EUR","LU0254981946.USD","LU2054465674.USD","LU2168563687.JPY","LU0661504455.SGD","LU1839511570.USD","LU1868837300.USD","LU0203347892.USD","LU0211328371.USD","LU2242649171.HKD","LU1400636657.SGD","LU2505996681.GBP","LU2168564222.USD","LU1720051017.SGD","GOOGL","LU2347655156.SGD","LU1791710400.SGD","LU0211331839.USD","LU1645745479.HKD","LU2097344431.USD","IE00BLSP4239.USD","LU2602419157.SGD","MUU","LU0820562030.AUD","LU0143551892.USD","LU2133065610.SGD","LU0238689110.USD","LU0276348264.USD","GOOX","LU0211326839.USD","IE000M9KFDE8.USD","LU1699723380.USD","HK0000819398.USD","AIFD","LU0127658192.USD","LU2746668974.SGD","IE00BK4W5M84.HKD","IE00BMPRXN33.USD","LU2077746001.SGD","LU1201861165.SGD","LU1852331112.SGD","BK4503","IE00BSNM7G36.USD","LU0449509016.USD","LU0289739343.SGD","LU0345774391.USD","FTEC","FXL","LU0545039389.USD","LU0690374615.EUR","LU0106261372.USD","BK4534","LU1868838027.USD","IE0000B7K699.USD","LU0289739699.SGD","BK4533","LU0149725797.USD","LU0957791311.USD","LU2750360997.AUD","LU0957808578.USD","LU1974910355.USD","LU0109394709.USD","LU1267930490.SGD","LU1267930227.SGD","METV","SOXX","LU1121112475.USD","LU0029864427.USD","LU1670627923.USD","LU0289961442.SGD","LU2092627202.USD","SHOC","LU1868836914.USD","LU0011850046.USD","BBH","SGXZ81514606.USD","LU2236285917.USD","IE0002270589.USD","LU0786609619.USD","LU1059921491.USD","LU0310799852.SGD","LU1119994496.HKD","LU1804176565.USD","TBXU","LU1506573853.SGD","SKYY","LU2125154778.USD","LU2065169927.USD","LU1430594728.SGD","IE00B19Z3B42.SGD","CHAT","LU1244550494.USD","IE00BLSP4452.SGD","HK0000532082.HKD","LU0444971666.USD","LU2191332357.HKD","IE00BZ1G4Q59.USD","LU1894683264.USD","BOBP","LU0107464264.USD","SMH","LU0106259046.USD","LU0708994859.HKD","LU2089283258.USD","LU0868494617.USD","LU1935043452.HKD","CGGO","IE00BBT3K403.USD","LU1868837565.USD","LU0154236417.USD","LU0265266980.USD","BK4585","LU0310800965.SGD","LU0198837287.USD","MULL","LU1951198990.SGD","OGIG","LU0057025933.USD","LU1823568750.SGD","LU2491049909.HKD","LU0061474705.USD","BK4512","LU2125154935.USD","LU1914381329.SGD","GOGL","LU0061475181.USD","LU2089284900.SGD","LU1951200564.SGD","LU0788109048.HKD","BK4573","LU0994945656.USD","LU0320765059.SGD","LU2324357040.USD","LU0234572021.USD","LU2065171311.SGD","LU2417539215.USD","FAI","LU0672654240.SGD","GB00BDT5M118.USD","LU0342679015.USD","LU2347655073.USD","LU2264538146.SGD","LU1935042991.SGD","LU2063271972.USD","IE0034235303.USD","LU0323240290.USD","LU1032955483.USD","LU0130518102.USD","LU0256863811.USD","LU0889565833.HKD","SG9999004303.SGD","LU1548497426.USD","LU0943347566.SGD","LU0072463663.USD","LU2471134796.USD","LU2756315664.SGD","LU0531970944.HKD","LU0823421416.USD","LU2931357623.SGD","GXPC","LU1323610961.USD","MEI.AU","IBB","LU0689472784.USD","IE0034235188.USD","LU0426412945.USD","LU0096362180.USD","LU0719512351.SGD","ARTY","LU0314106906.USD","BK4527","BK4550","NKE","SG9999015952.SGD","IE00BK4W5L77.USD","LU0251143458.SGD","LU1989772923.USD","IE00BYXW3230.USD","MU","LU2458330169.SGD","BK4141","LU1633808545.USD","LU1868836591.USD","LU2271345857.HKD","BK4139","LU0345770993.USD","LU2065171402.SGD","LU0545562505.USD","LU1935042215.USD","GGLL","IE00BFXG0V08.USD","ILDR","LU2065170008.USD","IE00BMPRXQ63.HKD","HK0000914660.USD","LU0053687314.USD","DRMY","LU0795875169.SGD","LU0683600562.USD","GOOP","LU0823046494.USD","BK4553","IE00BFSS7M15.SGD","XDAT","LU1064131342.USD","LU0158827948.USD","LU2360106780.USD","LU0784385840.USD","LU0320765489.SGD","LU1400636491.USD","SG9999002232.USD","LU1861220207.SGD","IE00BFSS8Q28.SGD","LU0261950470.USD","LU1989772840.SGD","LU0859254822.USD","LU0980610538.SGD","LU0196696701.USD","LU2403377893.USD","LU0795875086.SGD","SG9999014914.USD","BK4566","LU0345770308.USD","LU0109391861.USD","LU0208291251.USD","LU1400636574.HKD","LU2860962120.EUR","LU0086394185.USD","LU0742534661.SGD","CHPS","LU1032466523.USD","BK4532","CQTM","SG9999018857.SGD","LU1267930813.SGD","LU0109392836.USD","LU0211326755.USD","BK7095","LU2244417387.USD","LU0210536198.USD","LU1861215975.USD","LU1803068623.USD","LU0302445910.USD","LU1366333091.USD","LU0572108347.SGD","LU1868837136.USD","LU0426417589.USD","LU2471134952.CNY","GGLS","LU2089985449.USD","LU0256863902.USD","LU0942090050.USD","LU1116320901.HKD","LU0345768153.USD","MUZ","STYL","BK4543","IE00BYQQ9H92.USD","BK4007","LU1718418525.SGD","LU0823434583.USD","LU0080751232.USD","LU0738911758.USD","LU0256859116.SGD","BK4514","IE000BZT7R73.USD","SG9999014559.SGD","LU0211327993.USD","LU0354030511.USD","LU1429558221.USD","XLK","SG9999014567.USD","LU0889566641.SGD","LU0823421333.USD","LU2420271590.USD","LU1551013342.USD","LU0175139822.USD","LU0898699433.AUD","GB00B4LPDJ14.GBP","LU0396314238.USD","LU1235294995.USD","LU0353189763.USD","LU0494093205.USD","LU1066051225.USD","LU0528227936.USD","LU2954938101.SGD","LU2102340556.USD","LU1267930730.SGD","LU1935043536.SGD","IE00BWXC8680.SGD","LU2756315318.SGD","LU1244550221.USD","SGXZ23171101.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672530277","title":"Sanofi’s Regeneron Fix Requires Extra Shot of M&A","url":"https://stock-news.laohu8.com/highlight/detail?id=2672530277","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672530277?lang=en_us&edition=fundamental","pubTime":"2026-10-01 17:13","pubTimestamp":1790846033,"startTime":"0","endTime":"0","summary":"BREAKINGVIEWS-Sanofi’s Regeneron fix requires extra shot of M&ADUBLIN, Oct 1 (Reuters Breakingviews)-SanofiSASY.PAhas taken the first step to treating a long list of ailments. On Thursday, the $100 bi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nL6N45N0JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03165","LU0345777659.USD","LU0784385170.HKD","LU1989772923.USD","LU1883839398.USD","LU0889565916.HKD","FTXH","LU0225284248.USD","LU0738911758.USD","LU1481600234.SGD","LU1571399168.USD","LU1814569148.SGD","BK5011","LU0784383803.USD","BBH","LU1496350171.SGD","IBB","LU2293690082.USD","LU3187612489.SGD","AZN.UK","BMY","IBBQ","LU1868836914.USD","LU0289739699.SGD","BK4581","LU0171276677.USD","LU1236620750.USD","LU1153584641.USD","LU1496350502.SGD","LU0526926950.USD","TBXU","LU1170363599.USD","IE00BJT1NW94.SGD","REGN","LU0306806265.USD","LU2125154935.USD","LU2125909593.SGD","LU0757432116.USD","BK4585","IE00BKPKM643.USD","LU1670710661.SGD","LU0211327993.USD","LU1868836757.USD","LU2125909247.SGD","LU0784385840.USD","IHE","LU0211326755.USD","SG9999013999.USD","LU0114720955.EUR","LU0857590862.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672758407","title":"Sanofi CEO Takes First Step Toward Addressing Long-Term Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2672758407","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672758407?lang=en_us&edition=fundamental","pubTime":"2026-10-01 16:09","pubTimestamp":1790842140,"startTime":"0","endTime":"0","summary":"0809 GMT - Sanofi's expanded alliance with Regeneron Pharmaceuticals represents the French drugmaker's first step toward addressing its long-term outlook and should be seen as a clear sign of progress under new CEO Belen Garijo, Jefferies analysts write in a research note. \"While the assets are early-stage, the expansion should be viewed positively, as it signals the new CEO's proactive focus on the most important yet addressable uncertainties investors face, as well as the speed of progress,\" the analysts say. Potential acquisitions and a settlement to delay the arrival of copycat versions of the alliance's blockbuster drug Dupixent are other key steps Sanofi needs to take to address the sales hole left by that medicine's patent expiration between 2031 and 2032, the analysts add. Sanofi shares rise 0.6%.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1917777945.USD","LU2237438978.USD","LU2362540622.SGD","BK4588","SNY","LU0109394709.USD","LU0289739699.SGD","LU0320765992.SGD","LU0114720955.EUR","LU2362541273.HKD","TBXU","LU2023250504.SGD","LU0823416689.USD","LU1974910355.USD","SNYNF","LU0889565916.HKD","LU0058720904.USD","REGN","LU2362541513.USD","LU0053666078.USD","LU2324357040.USD","BK4139","LU2106854487.HKD","IE00BFXG1179.USD","BBH","LU2468319806.SGD","LU0882574055.USD","BK4007","BK4585","LU2089984988.USD","IBBQ","IBB","LU0823434583.USD","LU0823434740.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672073056","title":"Sanofi to Get Pipeline Boost from Expanded Regeneron Alliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2672073056","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672073056?lang=en_us&edition=fundamental","pubTime":"2026-10-01 15:10","pubTimestamp":1790838600,"startTime":"0","endTime":"0","summary":"0709 GMT - Sanofi's deal to expand its alliance with U.S. peer Regeneron Pharmaceutical provides a boost to the French company's early-stage drug pipeline, J.P. Morgan analysts write in a research note. The conclusion of the negotiations with Regeneron is positive for Sanofi, the analysts say. Sanofi will pay Regeneron $1 billion upfront, and up to $7 billion subject to certain targets to get access to four new drug candidates invented by its partner. Now that an agreement with Regeneron has been reached, Sanofi investors are likely to switch their focus to the company's moves to strengthen its business through dealmaking, the analysts say. Sanofi shares rise 2%.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","IBBQ","BK4585","BK4007","LU2023250504.SGD","LU0053666078.USD","LU0823434740.USD","LU2468319806.SGD","SNY","BK4588","LU2237438978.USD","BK4139","LU2106854487.HKD","LU2362540622.SGD","LU0109394709.USD","LU2324357040.USD","IBB","BBH","LU0889565916.HKD","TBXU","LU0058720904.USD","LU0882574055.USD","IE00BFXG1179.USD","LU0289739699.SGD","LU0823434583.USD","LU0320765992.SGD","LU2362541513.USD","LU1974910355.USD","LU2362541273.HKD","REGN","SNYNF","LU1917777945.USD","LU0114720955.EUR","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}